A team of researchers decided to show that perhaps it’s time to work on improving the effects of existing therapies.
Salk scientists have found the antioxidant fisetin to be beneficial in mouse model of premature aging, Alzheimer's disease.
Blocking a key placental defense may limit maternal-fetal transmission of the virus.
A new study has examined whether it’s possible to teach old drugs new tricks in the fight against infectious diseases.
New research may ultimately help athletes and trainers better understand who may be more at risk for heat stroke.
Research has revealed cathepsins as potential therapeutic targets in particulate-mediated inflammatory disease.
Scientists believe they’ve solved the structure of a protein that helps a common respiratory virus evade the immune system.
The causes of brain cell death that occur in patients with Alzheimer's disease remain unknown and are, therefore, a barrier to developing effective therapies.
New treatment lasts more than two weeks in primates, promising to eclipse current treatment options in humans.
A single treatment giving life-long protection from severe allergies could be made possible by immunology research.
Researchers used evolutionary principles to explore sustainable antibiotic treatment strategies.
The critical component of an experimental vaccine led to an escalating immune response in patients with sarcoma.
Study results have offered a safe and affordable treatment option.
A new enhanced test detects significantly more bacteria than the standard test.
A new medicine developed to treat severe asthma has shown promising results in a medical trial.
The time has come for advancing combination therapies against Alzheimer's disease, said the Alzheimer's Association director of global science initiatives.
Researchers have discovered that a new drug significantly reduces their risk of death and need for transplantation.
The new drug would ideally have fewer side effects and eliminate the need for insulin injections.
A custom-engineered protein destroyed the deadly virus in the lab.
An NIH co-funded clinical trial tested an alternative treatment for eosinophilic syndrome.
So far it has not been possible to develop vaccines capable of contributing to the treatment and prevention of HIV and hepatitis C.
Targeting the mast cells with imatinib improved airway hyper-responsiveness in patients with severe asthma.
Scientists have developed a type of eye drop that could potentially revolutionize the treatment of one of the leading causes of blindness in the U.K.
The newly revealed disease mechanism points to a potential target for treatment.
Scientists have uncovered evidence that a deficiency in the skin's barrier is key to triggering eczema.
The current FDA standards pose an unnecessarily challenging hurdle that may be inhibiting investment in new Alzheimer's treatments, the authors said.
Evidence in preclinical models shows that Hinokitiol may correct anemia caused by genetic deficiencies.
Researchers have identified a potent new weapon against the Zika virus in the blood of people who have been infected by it.
Pediatric patients have high complication rates that increase each day infections linger untreated.
Technique increases types of cells in pancreas that make insulin.
Researchers said carriers of a specific genotype could be evaluated earlier for liver transplants.
A blood test done within seven days of vaccination can predict whether vaccines based on living, modified viruses have had the desired effect.
A clinical trial has discovered a drug combination that could help thousands of children with arthritis.
NIH rat study suggests amitriptyline temporarily inhibits the blood-brain barrier, allowing drugs to enter the brain.
While it was not the goal of this study to measure how effective the treatment was, symptoms improved for three of the six participants.
Once the team refines the method, the pill could join the syringe as a DNA delivery system.
NIH-funded research has shown that genes may help determine optimal treatments.
A new study could lead to new treatments for a broad range of conditions and diseases.
As many as 600 million people in Southeast Asia chew areca nuts with betel leaves, sometimes adding tobacco leaves.
Scientists have found that a class of heart failure drugs might decrease LDL cholesterol levels in patients who do not respond to statins.
The protein may help make vaccinations more effective and provide protection from other diseases such as cancer.
First-ever global symposium convenes to review latest science on natural sweetener.
Researchers may have found a natural way to cut down on antibiotic use without sacrificing health.
There’s a new treatment pathway for antibiotic resistant bacteria and infectious diseases with benefits for patients and healthcare providers.
Scientists say the innovation could put their vaccine candidate among the safest yet reported.
Researchers examined how a clinical trial on one drug's efficacy affected its use in ambulances across the country.
The team said that the improved adjuvant formulations could reduce side effects.
The study provides the first direct evidence of opiate-related epigenetic alterations in the human brain.
The researchers want to target therapies to distinct "nodes or clusters" of patients based on specific symptoms or molecular features of their disease.
A new class of cholesterol-lowering drug has been found to help patients cut their risk of cardiovascular disease, stroke and heart attack.